BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 468514)

  • 1. Systematic review of the risk of urolithiasis following parathyroidectomy in patients with primary hyperparathyroidism.
    Wang X; Shi G; Li G; Tang G
    Int Urol Nephrol; 2024 Apr; 56(4):1217-1225. PubMed ID: 38038823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical characterization of primary hyperparathyroidism with and without kidney stones.
    Odvina CV; Sakhaee K; Heller HJ; Peterson RD; Poindexter JR; Padalino PK; Pak CY
    Urol Res; 2007 Jun; 35(3):123-8. PubMed ID: 17476495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary hyperparathyroidism: renal calcium excretion in patients with and without renal stone sisease before and after parathyroidectomy.
    Frøkjaer VG; Mollerup CL
    World J Surg; 2002 May; 26(5):532-5. PubMed ID: 12098039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk of nephrolithiasis with oral calcium supplementation.
    Ringe JD
    Calcif Tissue Int; 1991 Feb; 48(2):69-73. PubMed ID: 2013015
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary hyperparathyroidism: epidemiology, diagnosis and clinical picture.
    Ljunghall S; Hellman P; Rastad J; Akerström G
    World J Surg; 1991; 15(6):681-7. PubMed ID: 1767533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of citric acid in primary hyperparathyroidism with renal lithiasis.
    Alvarez-Arroyo MV; Traba ML; Rapado A; de la Piedra C
    Urol Res; 1992; 20(1):88-90. PubMed ID: 1736494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of citrate on the different phases of calcium oxalate crystallization.
    Tiselius HG; Berg C; Fornander AM; Nilsson MA
    Scanning Microsc; 1993 Mar; 7(1):381-9; discussion 389-90. PubMed ID: 8316807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurements of urinary state of saturation with respect to calcium oxalate and brushite (CaHPO4.2H2O) in renal stone formers.
    Sriboonlue P; Prasongwattana V; Tungsanga K; Sitprija V
    J Med Assoc Thai; 1990 Dec; 73(12):684-9. PubMed ID: 2086716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body size and 24-hour urine composition.
    Taylor EN; Curhan GC
    Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of prolonged bedrest on the propensity for renal stone formation.
    Hwang TI; Hill K; Schneider V; Pak CY
    J Clin Endocrinol Metab; 1988 Jan; 66(1):109-12. PubMed ID: 3335600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased risk of urinary stone disease by physical exercise.
    Sriboonlue P; Prasongwatana V; Tosukhowong P; Tungsanga K; Bovornpadoongkitti S
    Southeast Asian J Trop Med Public Health; 1996 Mar; 27(1):172-7. PubMed ID: 9031423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of parathyroidectomy on crystallization of calcium salts in urine of patients with primary hyperparathyroidism.
    Pak CY
    Invest Urol; 1979 Sep; 17(2):146-8. PubMed ID: 468514
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.